Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Prostaglandin Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN105254657B details a rhodium-catalyzed route for prostaglandin analogs, offering milder conditions and reduced toxicity for reliable supply chain integration.
Patent CN101003504B details an asymmetric synthesis for high-purity prostaglandin intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN114921507B reveals lipase resolution for 2-oxabicyclo-[3.3.0]oct-6-en-3-one. High purity, green process, reliable supply chain for pharmaceutical intermediates.
Patent CN1732149A details a scalable Claisen rearrangement for 3,3a,6,6a-tetrahydro-2H-cyclopenta[b]furan-2-one, offering cost reduction and high purity for pharmaceutical manufacturing.
Patent CN1990450A discloses a novel silylation strategy for prostaglandin F derivatives, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN1990450A details a selective silylation route for high-purity prostaglandin intermediates, offering significant cost reduction in ophthalmic API manufacturing.
Patent CN108084129B details a novel enantioselective Baeyer-Villiger oxidation for prostaglandin intermediates, offering high ee values and scalable manufacturing solutions.